This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

Study finds it's cost-effective to diagnose intellectual disabilities with whole genome sequencing

Study finds it is cost-effective to diagnose intellectual disabilities with whole genome sequencing
Cumulative progression of diagnostic yield per cohort. Credit: Scientific Reports (2023). DOI: 10.1038/s41598-023-33787-8

Researchers at Karolinska Institutet and Karolinska University Hospital have together with health economists at Linköping University analyzed costs for various methods to diagnose genetic causes of intellectual disability. The study, published in Scientific Reports, shows that the costs when using whole genome sequencing as a first-line diagnostic test were lower compared to chromosomal microarray analysis.

An examination of the entire gene set, so-called sequencing, WGS, gives a better answer than previous methods when are investigated, and new findings shows that the method is also more cost-effective.

In this study, a health economic evaluation was made of 89 individuals with , ID, who underwent early diagnostics with at the Clinical Genetics Department at Karolinska University Hospital. After two years, 9.4% lower health care costs per individual were observed compared to 418 individuals who underwent traditional genetic investigation using micro-array technology, CMA.

"The study shows that WGS as a first-line diagnostic test for individuals with ID is associated with lower costs and a higher diagnostic yield compared with CMA," says Anna Lindstrand, Senior Physician and Professor of Clinical Genetics at the Research Group Rare Diseases, Department of Molecular Medicine and Surgery.

This indicates that whole genome sequencing should be used as the dominant strategy when investigating these individuals.

More information: Hannes Runheim et al, The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders, Scientific Reports (2023). DOI: 10.1038/s41598-023-33787-8

Journal information: Scientific Reports
Citation: Study finds it's cost-effective to diagnose intellectual disabilities with whole genome sequencing (2023, May 4) retrieved 27 February 2024 from https://medicalxpress.com/news/2023-05-cost-effective-intellectual-disabilities-genome-sequencing.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Genome sequencing as a first-line test to diagnose intellectual disability

5 shares

Feedback to editors